VANGUARD GROUP INC - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 22 filers reported holding LANTERN PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$1,253,019
-39.5%
367,4540.0%0.00%
Q2 2023$2,072,440
+16.8%
367,4540.0%0.00%
Q1 2023$1,774,803
-20.0%
367,4540.0%0.00%
Q4 2022$2,219,422
+26.4%
367,454
+0.0%
0.00%
Q3 2022$1,756,000
-16.3%
367,3190.0%0.00%
Q2 2022$2,097,000
-20.1%
367,3190.0%0.00%
Q1 2022$2,626,000
-10.7%
367,319
-0.4%
0.00%
Q4 2021$2,942,000
-2.8%
368,704
+36.1%
0.00%
Q3 2021$3,027,000
-23.0%
270,820
+0.5%
0.00%
Q2 2021$3,933,000
-16.3%
269,429
+4.0%
0.00%
Q1 2021$4,701,000259,1470.00%
Other shareholders
LANTERN PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
CM Management, LLC 75,000$255,7500.27%
Redmond Asset Management, LLC 46,506$158,5850.06%
Pathway Financial Advisors LLC 32,771$111,7490.04%
CARLSON CAPITAL L P 95,000$323,9500.02%
NewEdge Advisors, LLC 170,031$579,8280.01%
WOLFF WIESE MAGANA LLC 2,200$7,5020.01%
Meridian Wealth Management, LLC 16,660$56,8110.00%
Sigma Planning Corp 18,125$61,8060.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 30,000$102,3000.00%
WELLS FARGO & COMPANY/MN 4,492$15,3180.00%
View complete list of LANTERN PHARMA INC shareholders